358126908	358126908	CD	B-NP	O
|	|	NN	I-NP	O
WR	WR	NN	I-NP	O
|	|	NN	I-NP	O
95072926	95072926	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
306133	306133	CD	B-NP	O
|	|	CC	I-NP	O
2/20/1997	2/20/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/16/1997	5/16/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/12/1997	3/12/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
FLASH	FLASH	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
EDEMA	EDEMA	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
DEPRESSION	DEPRESSION	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GLAUCOMA	GLAUCOMA	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

NON-INSULIN-DEPENDENT	NON-INSULIN-DEPENDENT	JJ	B-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

MITRAL	MITRAL	JJ	B-NP	O
REGURGITATION	REGURGITATION	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
BREAST	BREAST	NNP	B-NP	O
CANCER	CANCER	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
POST	POST	NNP	I-NP	O
LEFT	LEFT	NNP	I-NP	O
MASTECTOMY	MASTECTOMY	NNP	I-NP	O
AND	AND	CC	O	O
TAMOXIFEN	TAMOXIFEN	NNP	B-NP	O
TREATMENT	TREATMENT	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
69-year-old	69-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CRF	CRF	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Darnbo	Darnbo	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
6/9/97	6/9/97	CD	B-NP	O
after	after	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
unrelieved	unrelieved	JJ	B-ADJP	O
by	by	IN	B-PP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
awakened	awaken	VBD	B-VP	O
her	her	PRP	B-NP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
was	be	VBD	B-VP	O
230/110	230/110	CD	B-NP	O
without	without	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
at	at	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	JJ	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
recently	recently	RB	B-ADVP	O
admitted	admit	VBD	B-VP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	IN	B-ADVP	O
to	to	TO	B-PP	O
Stonemep	Stonemep	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
with	with	IN	B-PP	O
anteroapical	anteroapical	JJ	B-NP	O
and	and	CC	I-NP	O
posterobasal	posterobasal	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
1997	1997	CD	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
diffuse	diffuse	JJ	B-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
vigorous	vigorous	JJ	B-NP	O
rehydration	rehydration	NN	I-NP	O
following	follow	VBG	B-VP	O
that	that	IN	B-SBAR	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
requiring	require	VBG	B-VP	O
intubation	intubation	NN	B-NP	O
from	from	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
following	follow	VBG	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
was	be	VBD	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
related	relate	VBN	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ha	Ha	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
RCA	RCA	NNP	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
ankle	ankle	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
coronary	coronary	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
post	post	VBP	B-VP	O
menopausal	menopausal	JJ	B-NP	O
status	status	NN	I-NP	O
without	without	IN	B-PP	O
hormone	hormone	NN	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
is	be	VBZ	B-VP	O
such	such	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-VP	O
one	one	CD	B-NP	O
block	block	NN	I-NP	O
or	or	CC	O	O
one	one	CD	B-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
having	have	VBG	I-VP	O
to	to	TO	I-VP	O
sit	sit	VB	I-VP	O
down	down	RP	B-PRT	O
at	at	IN	B-PP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
bench	bench	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mall	mall	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
266	266	CD	I-NP	O
down	down	IN	B-ADVP	O
to	to	TO	B-PP	O
193	193	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Breast	Breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
mastectomy	mastectomy	NN	B-NP	O
seven	seven	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
five	five	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
Tamoxifen	Tamoxifen	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
chemo	chemo	NN	I-NP	O
or	or	CC	I-NP	O
radiation	radiation	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypercalcemia	Hypercalcemia	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
no	no	DT	B-NP	O
alkalized	alkalize	VBN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
9/13	9/13	CD	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Glaucoma	Glaucoma	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Non-insulin-dependent	Non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
diagnosed	diagnose	VBD	B-VP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	IN	B-ADVP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Mitral	Mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
hormone	hormone	NN	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
years	year	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

TRANSFER	TRANSFER	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
started	start	VBD	B-VP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Timoptic	Timoptic	JJ	B-ADVP	O
0.25	0.25	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
GTT	GTT	NN	I-NP	O
OU	OU	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Serax	Serax	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
300	300	CD	I-NP	O
units	unit	NNS	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Tagamet	Tagamet	NN	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
and	and	CC	I-NP	O
adhesive	adhesive	JJ	I-NP	O
tape	tape	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
quit	quit	VBD	B-VP	O
17	17	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
uses	use	VBZ	B-VP	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
in	in	IN	B-PP	O
Lau	Lau	NNP	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
six	six	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
father	father	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
stomach	stomach	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Mother	Mother	NNP	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
aunts	aunt	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sister	sister	NN	B-NP	O
have	have	VBP	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
ages	age	NNS	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
60	60	CD	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
following	follow	VBG	I-VP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	B-protein
discharge	discharge	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
edema	edema	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
from	from	IN	B-PP	O
177	177	CD	B-NP	O
to	to	TO	I-NP	O
175	175	CD	I-NP	O
lb	lb	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
a	a	DT	B-NP	O
12	12	CD	I-NP	O
lb	lb	NN	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
or	or	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
female	female	NN	I-NP	O
,	,	,	O	O
resting	rest	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
98.5	98.5	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
156/68	156/68	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
right	right	JJ	B-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
using	use	VBG	I-VP	O
accessory	accessory	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
for	for	IN	B-PP	O
respirations	respiration	NNS	B-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
II-III/VI	II-III/VI	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
LSB	LSB	NNP	I-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
III/VI	III/VI	NN	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
distended	distend	VBN	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
ankle	ankle	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	O
was	be	VBD	B-VP	O
59	59	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
3.9	3.9	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
28.9	28.9	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
MCV	MCV	NN	B-NP	B-protein
82.3	82.3	CD	I-NP	I-protein
.	.	.	O	O

Magnesium	Magnesium	NNP	B-NP	O
was	be	VBD	B-VP	O
2.4	2.4	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
from	from	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
81	81	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
and	and	CC	I-NP	O
intervals	interval	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
QT	QT	NN	I-NP	O
slightly	slightly	RB	B-VP	O
increased	increase	VBN	I-VP	O
at	at	IN	B-PP	O
0.46	0.46	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
T	T	NN	B-NP	O
flattening	flattening	NN	I-NP	O
in	in	IN	B-PP	O
AVL	AVL	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
after	after	IN	B-PP	O
successful	successful	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
examination	examination	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
sided	sided	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Care	Care	NNP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
slowly	slowly	RB	B-ADVP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
present	present	VB	I-VP	O
a	a	DT	B-NP	O
prerenal	prerenal	JJ	I-NP	O
insult	insult	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
symptom	symptom	NN	B-NP	O
free	free	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
ever	ever	RB	I-VP	O
having	have	VBG	I-VP	O
had	have	VBD	I-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
known	know	VBN	I-VP	O
anatomy	anatomy	NN	B-NP	O
with	with	IN	B-PP	O
single	single	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RCA	RCA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
silent	silent	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetic	diabetic	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
6/2/97	6/2/97	CD	B-NP	O
with	with	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
plus	plus	CC	O	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Ticlid	Ticlid	NNP	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
target	target	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
140-160	140-160	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lopressor	Lopressor	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
30.9	30.9	CD	B-NP	O
and	and	CC	I-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/4/97	7/4/97	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
4.2	4.2	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
prerenal	prerenal	JJ	B-NP	O
insult	insult	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
possible	possible	JJ	B-NP	O
dinephropathy	dinephropathy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
hydrated	hydrate	VBN	I-VP	O
gently	gently	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
stabilizing	stabilize	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
4.4	4.4	CD	I-NP	O
to	to	TO	I-NP	O
4.5	4.5	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
:	:	:	O	O
Etiology	Etiology	NN	B-NP	O
was	be	VBD	B-VP	O
unknown	unknown	JJ	B-ADJP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
or	or	CC	O	O
hypertensive	hypertensive	JJ	B-NP	O
nephropathy	nephropathy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
rises	rise	VBZ	B-VP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	B-protein
3s	3	NNS	I-NP	I-protein
and	and	CC	I-NP	I-protein
4s	4	NNS	I-NP	I-protein
during	during	IN	B-PP	O
recent	recent	JJ	B-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
is	be	VBZ	B-VP	O
as	as	RB	I-VP	O
described	describe	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	B-protein
dosing	dosing	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
q.day	q.day	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
reviewing	review	VBG	B-VP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
records	record	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
and	and	CC	O	O
physical	physical	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
flash	flash	VB	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
was	be	VBD	B-VP	O
deferred	defer	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ANEMIA	ANEMIA	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
low	low	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-VP	O
Given	Give	VBN	I-VP	O
her	her	PRP	B-NP	O
underlying	underlie	VBG	B-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
renally	renally	RB	I-NP	O
driven	drive	VBN	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
Epogen	Epogen	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Andre	Andre	NNP	I-NP	O
Smithe	Smithe	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
previously	previously	RB	B-NP	O
scheduled	schedule	VBN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
times	time	NNS	I-NP	O
three	three	CD	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Timoptic	Timoptic	JJ	B-ADVP	O
0.25	0.25	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
OU	OU	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ticlid	Ticlid	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
tablet	tablet	NN	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
CBC	CBC	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
Ticlid	Ticlid	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LOUIS	LOUIS	NNP	B-NP	O
LIEBOLD	LIEBOLD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TV94	TV94	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
REFUGIO	REFUGIO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
HASSELL	HASSELL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SS00	SS00	NNP	I-NP	O
NJ125/0082	NJ125/0082	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
57174	57174	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

R8OH655T7B	R8OH655T7B	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/9/97	10/9/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/24/97	11/24/97	CD	B-NP	O

